Logistic strategy for molecule-targeting therapy in brain tumors
Logistic strategy for molecule-targeting therapy in brain tumors
批准号:
16390416
负责人:
MINEURA Katsuyoshi
金额:
$9.02万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
确定脑肿瘤的治疗管理是基于个体患者的宿主因素和肿瘤因素。目前,PET等功能神经成像技术的发展表征了脑肿瘤的生理生化过程等体内肿瘤因素。为了检测脑膜瘤的体内转运系统和肿瘤增殖,采用^<18> f -氟脱氧葡萄糖(FDG)或^<18> f -氟硼苯丙氨酸进行动力学分析,并比较其对血管内皮生长因子(VEGF)和葡萄糖转运蛋白-1 (Glut-1)的免疫反应性。K1在脑膜瘤中高于胶质瘤,在非典型脑膜瘤中高于良性脑膜瘤。k3与脑膜瘤的增殖指数mb -1 LI相关。免疫组化结果显示,脑膜瘤对VEGF或Glut-1的反应低于胶质瘤,但非典型脑膜瘤比良性脑膜瘤染色更强烈。K1和k3的高值表明脑膜瘤的侵袭性增殖,在更典型的脑膜瘤中,高通透性和大表面积的协同相互作用产生了有利于葡萄糖代谢和肿瘤增殖的条件。FDG的摄取和分布是判断恶性程度和肿瘤范围的重要标志。肿瘤部分包括FDG摄取峰值部分是准确诊断恶性肿瘤的目标。高级别胶质瘤表现出不均匀的摄取模式,反映了由聚集的肿瘤细胞、坏死和肿瘤周围水肿组成的细胞组成的地形变化。在大多数良性肿瘤中,如脑膜瘤和中枢神经细胞瘤,非典型亚群有相对较高的FDG摄取。当不典型时,可以最大限度地缩小肿瘤肿块。本研究表明logistic支持因子促进肿瘤生长,包括肿瘤血管生成。临床应用较少侵入性的功能图像提供了多学科生物学特征,并根据肿瘤因素进行更适当的治疗,并可能延长脑肿瘤患者的高水平表现状态。少
英文摘要
Determination of therapeutic management of brain tumors is based on both host factors of individual patients and tumor factors. Current development in functional neuroimaging such as PET characterizes in vivo tumor factors including physiological and biochemical process of brain tumors.To test in vivo transport system and tumor proliferation of meningiomas, kinetic analysis using ^<18>F-fluorodeoxyglucose (FDG) or ^<18>F-fluoroboronophenylalanine-was obtained and compared with immunoreactivity to vascular endothelial growth factor (VEGF) and glucose transporter-1 (Glut-1). K1 was higher in meningiomas than in gliomas, and was higher in atypical than in benign meningiomas. k3 was correlated with a proliferating index, MIB-1 LI, in meningiomas. Immunohistochemically, meningiomas were less reactive to VEGF or Glut-1 than gliomas, but atypical meningiomas stained more intensely than benign meningiomas. High values for K1 and k3 indicate the aggressive proliferation of meningiomas, and in a … More typical meningiomas, the synergistic interaction of the high permeability and the large surface area yielded conditions conducive to glucose metabolism and tumor proliferation.The uptake and distribution of FDG is important landmark for malignancy and tumor extent. The tumor portion including a peak FDG uptake portion is a target for accurate diagnosis of malignancy. High-grade gliomas show heterogeneous uptake patterns, reflecting a topographic variation of cellular composition consisting of aggregated tumor cells, necrosis, and peritumoral edema. Among mostly benign tumors such as meningioma and central neurocytoma, atypical subsets have a relatively high uptake of FDG. The maximum reduction of tumor mass may be applied, when atypical.The present study indicates that logistic support factors enhance tumor growth including tumor angiogenesis. Clinical use of functional image less invasively provides multidisciplinary biologic characteristics and leads to more appropriate treatment based on the tumor factors, and may result in prolonging high levels of performance status in brain tumors. Less
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
両側内頚動脈狭窄・閉塞症に対する外科的血行再建術および血管内治療の併用療法
手术血运重建与血管内治疗联合治疗双侧颈内动脉狭窄/闭塞
DOI:
--
发表时间:
2005
期刊:
脳卒中 27(2)(発表予定)
影响因子:
--
作者:
[井上靖夫, 法里高, 上田聖, 小坂恭彦, 天神博志, 大和田敬,峯浦一喜]
通讯作者:
大和田敬,峯浦一喜
PET findings and clinicopsychologic evaluation in anxious disturbance.
焦虑障碍的 PET 结果和临床心理评估。
DOI:
--
发表时间:
2004
期刊:
Progress in Medicine(in Japanese) 11
影响因子:
--
作者:
[Imahori Y, Maekawa M, Ohwada K, Sasajima H, Mineura K]
通讯作者:
Mineura K
運動の高次脳機能イメージング
运动的高级脑功能成像
DOI:
--
发表时间:
2004
期刊:
臨床スポーツ医学 21(9)
影响因子:
--
作者:
[峯浦一喜, 笹島浩泰, 今堀良夫]
通讯作者:
今堀良夫
Combination of surgical and endovascular treatments for bilateral carotid occlusive disease.
手术和血管内治疗相结合治疗双侧颈动脉闭塞性疾病。
DOI:
--
发表时间:
2005
期刊:
Jpn J Stroke(in Japanese) 27
影响因子:
--
作者:
[Inoue Y, Houri T, Ueda S, Osaka Y, Tenjin H, Mineura K]
通讯作者:
Mineura K
不安障害におけるPET所見と臨床心理学的評価
焦虑症的 PET 结果和临床心理评估
DOI:
--
发表时间:
2004
期刊:
Progress in Medicine 24(11)
影响因子:
--
作者:
[今堀良夫, 前川晶代, 大和田敬, 笹島浩泰, 峯浦一喜]
通讯作者:
峯浦一喜
Individually optimum therapy based on less invasive bio-imaging in brain yumors
-
批准号:18390401
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.56万
-
财政年份:2006
-
负责人:MINEURA Katsuyoshi
-
依托单位:
Clinical feasibility of individually optimal chemotherapy based on the molecular targets in brain tumors
-
批准号:14370443
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:2002
-
负责人:MINEURA Katsuyoshi
-
依托单位:
MOLECULAR-BASIS AUGMENTED CHEMOTHERAPY AND CLINICAL APPLICATION IN BRAIN TUMORS
-
批准号:12470296
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:2000
-
负责人:MINEURA Katsuyoshi
-
依托单位:
Strategy for Selective Brain Tumor Chemotherapy Involved in O^6-Methylguanine-DNA Methyltransferase
-
批准号:07457304
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1995
-
负责人:MINEURA Katsuyoshi
-
依托单位:
Molecular Biological Analysis for Augmented Brain Tumor Chemotherapy
-
批准号:05454392
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.52万
-
财政年份:1993
-
负责人:MINEURA Katsuyoshi
-
依托单位: